Oct
2026
Fiera Milano, Italy
Visit us
stand 12J17, Contract Manufacturing & Services

WuXi Biologics USA LLC

Exhibitor at CPHI Milan 2026
About Us

WuXi Biologics is a leading contract research, development and manufacturing organization providing end-to-end capabilities to healthcare organizations worldwide. With operations in the United States, Ireland, Germany, Singapore and China, we enable our partners to effectively and efficiently bring biologics and vaccines to patients worldwide through our comprehensive and high-quality drug development model.  WuXi XDC and WuXi Vaccines, two subsidiaries of WuXi Biologics, offer end-to-end platforms for the development and manufacture of bioconjugates and vaccines, respectively.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    United States
  • On CPHI since:
    2024
  • Employees:
    5000+
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Animal Health
Contract Manufacturer
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12J17, Contract Manufacturing & Services

WuXi Biologics USA LLC Resources (1)

  • WuXi Biologics Capabilities Overview

    Brochure WuXi Biologics Capabilities Overview

    As a leading CRDMO, WuXi Biologics integrates biologics services from concept through commercialization, delivering quality at every stage. We perform under the most demanding conditions, advancing programs at unmatched speed with expertise and assurance. Multi-modality discovery generates development-ready assets built for continuity. A growing pipeline supports over 660 IND approvals and25 commercial manufacturing programs. DNA reaches IND in as little as 6 months.